Organizational Structure

Through cross-sector and interdisciplinary collaboration, leveraging AI to accelerate new drug preclinical development.

By building a comprehensive non-clinical drug development service model, driving standardized ADMET validation.

AI-Driven Drug Development Program

AI-Empowered Drug Development Acceleration

AI Drug Development

Executed by: NSTC Division of Life Sciences

AI Software Technology Development

Executed by: NSTC Division of Engineering

Establishing Drug Development Validation Platform

Executed by: National Center for Biomodels, NIAR

Taiwan Contract Research One-Stop Service, T.CROSS

Assist in promoting and reviewing preclinical validation and translational research projects within the AI-driven drug development projects.

Executed by: Academia Sinica BioTReC, National Health Research Institutes, National Applied Research Laboratories, ITRI, Development Center for Biotechnology